Clinical Trial Update: Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 pilot study of simtuzumab for liver fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis

Drugs mentioned

• Simtuzumab (simtuzumab)

Snippet

Sponsor: Gilead Sciences | Conditions: Liver Fibrosis | Phase 2 | Status: COMPLETED